{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:25:46Z","timestamp":1792520746579,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd015171","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000}}],"reference-count":144,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd015171.pub2","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T07:18:10Z","timestamp":1677136690000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Systemic pharmacological interventions for M\u00e9ni\u00e8re\u2019s disease"],"prefix":"10.1002","volume":"2023","author":[{"given":"Katie E","family":"Webster","sequence":"additional","affiliation":[{"name":"Cochrane ENT; Nuffield Department of Surgical Sciences, University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Galbraith","sequence":"additional","affiliation":[{"name":"Cochrane ENT; Nuffield Department of Surgical Sciences, University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha A","family":"Harrington-Benton","sequence":"additional","affiliation":[{"name":"M\u00e9ni\u00e8re\u2019s Society; Wooton UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Judd","sequence":"additional","affiliation":[{"name":"ENT Department; University Hospitals of Derby and Burton NHS Foundation Trust; Derby UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Kaski","sequence":"additional","affiliation":[{"name":"National Hospital for Neurology and Neurosurgery; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto R","family":"Maarsingh","sequence":"additional","affiliation":[{"name":"Department of General Practice, Amsterdam UMC; Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"MacKeith","sequence":"additional","affiliation":[{"name":"ENT Department; Oxford University Hospitals NHS Foundation Trust; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaydip","family":"Ray","sequence":"additional","affiliation":[{"name":"University of Sheffield; Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent A","family":"Van Vugt","sequence":"additional","affiliation":[{"name":"Department of General Practice, Amsterdam UMC; Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Burton","sequence":"additional","affiliation":[{"name":"Cochrane UK; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"10.1002\/14651858.CD015171.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"h6816","DOI":"10.1136\/bmj.h6816","article-title":"Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)","volume":"352","author":"Adrion","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0002|cit2","unstructured":"Adrion C Enquiry from Cochrane ENT regarding the BEMED trial [personal communication] E-mail to: K Webster"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0003|cit3","doi-asserted-by":"crossref","unstructured":"Medical treatment of Meniere's disease with betahistine: a placebo-controlled, dose-finding study https:\/\/www.isrctn.com\/ISRCTN44359668 https:\/\/doi.org\/10.1186\/ISRCTN44359668","DOI":"10.1186\/ISRCTN44359668"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0004|cit4","unstructured":"Medical treatment of Meniere\u2019s disease with betahistine: a placebo-controlled, dose-finding study https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2005-000752-32\/DE"},{"issue":"3","key":"10.1002\/14651858.CD015171.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.amjoto.2015.12.007","article-title":"Treatment of M\u00e9ni\u00e8re's disease with intratympanic dexamethazone plus high dosage of betahistine","volume":"37","author":"Albu","year":"2016","journal-title":"American Journal of Otolaryngology"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.otohns.2004.08.01","article-title":"Randomized double-blinded, placebo-controlled clinical trial of famciclovir for reduction of M\u00e9ni\u00e8re\u2019s disease symptoms","volume":"131","author":"Derebery","year":"2004","journal-title":"Otolaryngology - Head and Neck Surgery"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0194-5998(03)01223-3","article-title":"Results of a randomized, placebo-controlled clinical trial of Famvir for active Meniere's disease","volume":"129","author":"Derebery","year":"2003","journal-title":"Otolaryngology - Head and Neck Surgery"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0008|cit8","unstructured":"Medical Report: Betahistine dihydrochloride and peripheral vertigo. A double blind, placebo-controlled trial in outpatients Supplied by Abbott"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0009|cit9","first-page":"114","article-title":"Effects of diuretic and vasodilator therapy in Meniere's Disease","volume":"27","author":"Khan","year":"2011","journal-title":"Biomedica"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00405-002-0524-4","article-title":"Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo","volume":"260","author":"Mira","year":"2003","journal-title":"European Archives of Oto-Rhino-Laryngology"},{"issue":"5","key":"10.1002\/14651858.CD015171.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/01.mao.0000185057.81962.51","article-title":"Oral administration of prednisone to control refractory vertigo in Meniere's disease: a pilot study","volume":"26","author":"Morales-Luckie","year":"2005","journal-title":"Otology and Neurotology"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0012|cit12","first-page":"44","article-title":"Multicenter randomized study on the efficacy of isosorbide in patients with M\u00e9ni\u00e8re's disease","volume":"15","author":"Park","year":"2016","journal-title":"Research in Vestibular Science"},{"issue":"3","key":"10.1002\/14651858.CD015171.pub2-BIB0013|cit13","first-page":"347","article-title":"Efficacy and safety of betahistine hydrochloride versus placebo in Meniere's disease","volume":"7","author":"Ricci","year":"1987","journal-title":"Revista Italiana di Otorinolaringologia Audiologia e Foniatria"},{"issue":"Suppl","key":"10.1002\/14651858.CD015171.pub2-BIB0014|cit14","first-page":"1","article-title":"The clinical drug trial in Meniere's disease with emphasis on the effect of betahistine SR","volume":"497","author":"Schmidt","year":"1992","journal-title":"Acta Oto-Laryngologica"},{"issue":"3","key":"10.1002\/14651858.CD015171.pub2-BIB0015|cit15","first-page":"789","article-title":"Treatment of problems of equilibrium and hearing with cinnarizine (R-516)","volume":"74","author":"Albernaz","year":"1968","journal-title":"Hospital"},{"issue":"1","key":"10.1002\/14651858.CD015171.pub2-BIB0016|cit16","first-page":"163","article-title":"Dorperidol in Meniere's disease","volume":"78","author":"Albernaz","year":"1970","journal-title":"Hospital"},{"issue":"7","key":"10.1002\/14651858.CD015171.pub2-BIB0017|cit17","first-page":"199","article-title":"Drug therapy of Meniere's disease","volume":"18","author":"Beckmann","year":"1970","journal-title":"HNO"},{"issue":"4","key":"10.1002\/14651858.CD015171.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4103\/indianjotol.INDIANJOTOL_47_17","article-title":"Role of antivirals in treatment of vertigo due to vestibulopathies","volume":"23","author":"Beigh","year":"2017","journal-title":"Indian Journal of Otology"},{"issue":"1","key":"10.1002\/14651858.CD015171.pub2-BIB0019|cit19","first-page":"31","article-title":"Modern methods of conservative and surgical treatment of Meniere's disease","volume":"34","author":"Beliakova","year":"1971","journal-title":"Vestnik Otorinolaringologii"},{"issue":"3","key":"10.1002\/14651858.CD015171.pub2-BIB0020|cit20","first-page":"325","article-title":"Treatment of endolymphatic edema with betahistine hydrochloride","volume":"21","author":"Bosch","year":"1970","journal-title":"Acta Oto-rino-laringologica Ibero-americana"},{"issue":"1","key":"10.1002\/14651858.CD015171.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/S0022215100092239","article-title":"The immediate effects of acetazolamide in Meniere's disease","volume":"96","author":"Brookes","year":"1982","journal-title":"Journal of Laryngology and Otology"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0022|cit22","first-page":"41","article-title":"Betahistine treatment for Meniere's syndrome","volume":"74","author":"Burkin","year":"1967","journal-title":"Clinical Medicine"},{"issue":"7","key":"10.1002\/14651858.CD015171.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1017\/S0022215100091283","article-title":"Betahistine in peripheral vertigo. A double-blind, placebo controlled, cross-over study of Serc versus placebo","volume":"95","author":"Canty","year":"1981","journal-title":"Journal of Laryngology and Otology"},{"issue":"5","key":"10.1002\/14651858.CD015171.pub2-BIB0024|cit24","first-page":"255","article-title":"Drugs used in the therapy of Meniere's disease","volume":"45","author":"Celestino","year":"1969","journal-title":"Il Valsalva"},{"issue":"3","key":"10.1002\/14651858.CD015171.pub2-BIB0025|cit25","first-page":"143","article-title":"Diuretics in Meniere's disease. The action of furosemide on vestibular reflectivity","volume":"81","author":"Celestino","year":"1970","journal-title":"Archivio Italiano di Otologia, Rinologia, Laringologia e Patologia Cervico-facciale"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1972.00490140033006","article-title":"Meclizine and placebo in treating vertigo of vestibular origin. Relative efficacy in a double-blind study","volume":"27","author":"Cohen","year":"1972","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD015171.pub2-BIB0027|cit27","first-page":"511","article-title":"Treatment of labyrinthine vertigo","volume":"16","author":"Conde Jahn","year":"1965","journal-title":"Acta Oto-rino-laringologica Ibero-americana"},{"issue":"10","key":"10.1002\/14651858.CD015171.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/00016489.2020.1777326","article-title":"Using betahistine in the treatment of patients with Meniere's disease: a meta-analysis with the current randomized-controlled evidence","volume":"140","author":"Devantier","year":"2020","journal-title":"Acta Oto-laryngologica"},{"issue":"9","key":"10.1002\/14651858.CD015171.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/MAO.0000000000001555","article-title":"Nocebo effect in Meniere's disease: a meta-analysis of placebo-controlled randomized controlled trials","volume":"38","author":"Dimitriadis","year":"2017","journal-title":"Otology & Neurotology"},{"issue":"5","key":"10.1002\/14651858.CD015171.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/archotol.1965.00760010496007","article-title":"A new treatment of Meniere's disease","volume":"82","author":"Dowdy","year":"1965","journal-title":"Archives of Otolaryngology"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0031|cit31","unstructured":"A prospectively randomized, placebo-controlled, double-blind, parallel groups study of betahistine dihydrochloride in patients presenting with vertigo and central signs on electronystagmography Supplied by Abbott Healthcare"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0032|cit32","unstructured":"Medical report: a double blind cross-over study of Serc (betahistine dihydrochloride), 36mg daily, versus placebo in outpatients with vertigo Supplied by Abbott Healthcare"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0033|cit33","unstructured":"A double-blind placebo-controlled study with betahistine (Betaserc\u00ae) in forms of vertigo eligible for drug treatment Supplied by Abbott Healthcare"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0034|cit34","unstructured":"Double-blind, randomised, multicentre study to compare Serc 8mg with placebo Supplied by Abbott Healthcare"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0035|cit35","first-page":"597","article-title":"Drug therapy in Meniere's syndrome: double blind study","volume":"93","author":"Elia","year":"1965","journal-title":"Medical Times"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.1966.03100150133043","article-title":"Double-blind evaluation of a new treatment for Meniere's syndrome","volume":"196","author":"Elia","year":"1966","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD015171.pub2-BIB0037|cit37","first-page":"24","article-title":"Long-term treatment of Meniere's disease","volume":"53","author":"Elia","year":"1970","journal-title":"International Surgery"},{"issue":"8","key":"10.1002\/14651858.CD015171.pub2-BIB0038|cit38","first-page":"519","article-title":"The treatment of M\u00e9ni\u00e8re's disease with betahistine: critical comments on the BEMED study","volume":"96","author":"Ernst","year":"2017","journal-title":"Laryngo-rhino-otologie"},{"issue":"610","key":"10.1002\/14651858.CD015171.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/pgmj.52.610.501","article-title":"Betahistine hydrochloride in Meniere's disease","volume":"52","author":"Frew","year":"1976","journal-title":"Postgraduate Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD015171.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/000331976501601102","article-title":"Pathogenesis and management of Meniere's syndrome in terms of microcirculation. Pharmacologic decompression of the endolymphatic hydrops","volume":"16","author":"Godlowski","year":"1965","journal-title":"Angiology"},{"issue":"3","key":"10.1002\/14651858.CD015171.pub2-BIB0041|cit41","first-page":"227","article-title":"Treatment of Meniere's vertigo with betahistine","volume":"47","author":"Greiner","year":"1975","journal-title":"Revue d'Oto-neuro-ophtalmologie"},{"issue":"8","key":"10.1002\/14651858.CD015171.pub2-BIB0042|cit42","first-page":"25","article-title":"Meniere's disease. (Preliminary report of a new treatment)","volume":"12","author":"Guay","year":"1970","journal-title":"Applied Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD015171.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000111044","article-title":"Intratympanic application of an antiviral agent for the treatment of Meniere's disease","volume":"70","author":"Guyot","year":"2008","journal-title":"ORL; Journal for Oto-rhino-laryngology and Its Related Specialties"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0044|cit44","first-page":"177","article-title":"Effect of cinnarizine on various types of vertigo. Clinical and electronystagmographic results of a double-blind study","volume":"43","author":"Hausler","year":"1989","journal-title":"Acta Oto-rhino-laryngologica Belgica"},{"issue":"8","key":"10.1002\/14651858.CD015171.pub2-BIB0045|cit45","first-page":"632","article-title":"Study: betahistine in Meniere's disease is no more effective than placebo","volume":"65","author":"Helling","year":"2017","journal-title":"HNO"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/00016487209122699","article-title":"A study of the efficacy of betahistine in Meniere's syndrome","volume":"305","author":"Hommes","year":"1972","journal-title":"Acta Oto-laryngologica. Supplementum"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD015171.pub2-BIB0047|cit47","article-title":"Betahistine in a twice or thrice daily regimen. Comparative, randomized open study in two groups of patients with recurrent vertigo","volume":"41","author":"Huy","year":"1992","journal-title":"Journal Fran\u00e7ais d'Otorhinolaryngologie"},{"issue":"9","key":"10.1002\/14651858.CD015171.pub2-BIB0048|cit48","first-page":"565","article-title":"Meniere's disease","volume":"2003","author":"James","year":"2003","journal-title":"Clinical Evidence"},{"issue":"12","key":"10.1002\/14651858.CD015171.pub2-BIB0049|cit49","first-page":"742","article-title":"Meniere's disease","volume":"2004","author":"James","year":"2004","journal-title":"Clinical Evidence"},{"issue":"13","key":"10.1002\/14651858.CD015171.pub2-BIB0050|cit50","first-page":"519","article-title":"Treatment of Meniere's disease","volume":"116","author":"Jongkees","year":"1972","journal-title":"Nederlands Tijdschrift voor Geneeskunde"},{"issue":"4","key":"10.1002\/14651858.CD015171.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/00016486709128769","article-title":"Meniere's disease and hydrochlorothiazide (Dichlotride) - a critical analysis of symptoms and therapeutic effects","volume":"63","author":"Klockhoff","year":"1967","journal-title":"Acta Oto-Laryngologica"},{"issue":"6","key":"10.1002\/14651858.CD015171.pub2-BIB0052|cit52","first-page":"707","article-title":"Therapeutic usefulness of Diphergan (Polfa) in the light of clinical and experimental studies","volume":"26","author":"Klonowski","year":"1972","journal-title":"Otolaryngologia Polska"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0053|cit53","first-page":"97","article-title":"Therapeutic management of Meniere's syndrome","volume":"13","author":"Lazeanu","year":"1968","journal-title":"Oro-rino-laringologie"},{"issue":"12","key":"10.1002\/14651858.CD015171.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1017\/S0022215120002509","article-title":"The benefits of betahistine or vestibular rehabilitation (Tetrax biofeedback) on the quality of life and fall risk in patients with Meniere's disease","volume":"134","author":"Liu","year":"2020","journal-title":"Journal of Laryngology and Otology"},{"issue":"6","key":"10.1002\/14651858.CD015171.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010696.pub2","article-title":"Betahistine for symptoms of vertigo","author":"Murdin","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD015171.pub2-BIB0056|cit56","first-page":"739","article-title":"Treatment of Meniere's disease with ganglioplegic drugs","volume":"27","author":"Najwer","year":"1973","journal-title":"Otolaryngologia Polska"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0057|cit57","unstructured":"Famvir for treatment of hearing in unilateral M\u00e9ni\u00e8re's disease https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01526408"},{"issue":"5","key":"10.1002\/14651858.CD015171.pub2-BIB0058|cit58","first-page":"650","article-title":"Therapeutic results of betahistine on Meniere's disease. Multi-variable analysis of the results of the double blind test and Fisher's evaluation method","volume":"22","author":"Okamoto","year":"1968","journal-title":"Iryo"},{"issue":"1","key":"10.1002\/14651858.CD015171.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0022215100146158","article-title":"Betahistine dihydrochloride in the treatment of vertigo of peripheral vestibular origin. A double-blind placebo-controlled study","volume":"98","author":"Oosterveld","year":"1984","journal-title":"Journal of Laryngology and Otology"},{"issue":"9","key":"10.1002\/14651858.CD015171.pub2-BIB0060|cit60","first-page":"483","article-title":"Study of a programmed release preparation of betahistine mesylate in the treatment of Meniere's disease (author's transl)","volume":"98","author":"Pialoux","year":"1981","journal-title":"Annales d'Oto-laryngologie et de Chirurgie Cervico Faciale"},{"issue":"6","key":"10.1002\/14651858.CD015171.pub2-BIB0061|cit61","first-page":"573","article-title":"Histamine in the treatment of Meniere's disease","volume":"29","author":"Popiel","year":"1975","journal-title":"Otolaryngologia Polska"},{"issue":"1","key":"10.1002\/14651858.CD015171.pub2-BIB0062|cit62","first-page":"196","article-title":"Histamin treatment of Meniere's disease","volume":"20","author":"Przymanowski","year":"1966","journal-title":"Otolaryngologia Polska"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0063|cit63","unstructured":"A double-blind, placebo-controlled, randomized, clinical study of the effects of Betaserc\u00ae 24 mg (1 tablet b.i.d over 3 months) on vestibular compensation following vestibular neurotomy in patients with disabling M\u00e9ni\u00e8re's disease http:\/\/clinicaltrials.gov\/show\/nct00160238"},{"issue":"4","key":"10.1002\/14651858.CD015171.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/0091270010369241","article-title":"Betahistine treatment improves the recovery of static symptoms in patients with unilateral vestibular loss","volume":"51","author":"Redon","year":"2011","journal-title":"Journal of Clinical Pharmacology"},{"issue":"41","key":"10.1002\/14651858.CD015171.pub2-BIB0065|cit65","first-page":"915","article-title":"Therapy of peripheral vestibular vertigo with betahistine dimesilate (Aequamen)","volume":"125","author":"Reker","year":"1983","journal-title":"Munchener Medizinische Wochenschrift"},{"issue":"242","key":"10.1002\/14651858.CD015171.pub2-BIB0066|cit66","first-page":"759","article-title":"Meniere's disease","volume":"207","author":"Richards","year":"1971","journal-title":"Practitioner"},{"issue":"3","key":"10.1002\/14651858.CD015171.pub2-BIB0067|cit67","first-page":"302","article-title":"Double blind study between betahistine hydrochloride and placebo in the treatment of Meniere's syndrome","volume":"60","author":"Salami","year":"1984","journal-title":"Il Valsalva"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0068|cit68","first-page":"262","article-title":"Initial findings in the treatment of Meniere's disease with betahistine hydrochloride (Betaserc)","volume":"26","author":"Segers","year":"1972","journal-title":"Acta Oto-rhino-laryngologica Belgica"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0069|cit69","unstructured":"\u00a0Double-blind, multi-center, randomized, comparative study of Serc \u00ae 24mg versus Placebo, in two groups of patients with recurrent vertigo. Addendum to clinical report Supplied by Abbott Healthcare"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0070|cit70","unstructured":"Analyses of patients suffering from Meniere's disease. Addendum to Clinical Report. Double-blind, multi-centre, randomised, comparative study of SercB 24 mg versus placebo, in two groups of patients with recurrent vertigo Supplied by Abbott Healthcare"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0071|cit71","unstructured":"Double-blind, multi-centre, randomised, comparative study of Serc \u00ae24 mg versus placebo, in two groups of patients with recurrent vertigo\u00a0 Supplied by Abbott Healthcare"},{"issue":"5","key":"10.1002\/14651858.CD015171.pub2-BIB0072|cit72","first-page":"287","article-title":"Use of a diuretic (Dyazide) in the treatment of Meniere's disease. A double-blind cross-over placebo-controlled study","volume":"48","author":"Deelen","year":"1986","journal-title":"ORL; Journal for Oto-rhino-laryngology and Its Related Specialties"},{"issue":"1","key":"10.1002\/14651858.CD015171.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000515821","article-title":"Betahistine in Meniere's disease or syndrome: a systematic review","volume":"27","author":"Van Esch","year":"2022","journal-title":"Audiology & Neuro-otology"},{"issue":"11","key":"10.1002\/14651858.CD015171.pub2-BIB0074|cit74","first-page":"1237","article-title":"Evaluation of the effect of betahistine in Meniere's disease by double-blind test and multivariate analysis","volume":"39","author":"Watanabe","year":"1967","journal-title":"Jibi Inkoka Otolaryngology"},{"issue":"9","key":"10.1002\/14651858.CD015171.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1017\/S0022215100082785","article-title":"Betahistine in Meniere's disease","volume":"90","author":"Wilmot","year":"1976","journal-title":"Journal of Laryngology and Otology"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0076|cit76","first-page":"891","article-title":"Meniere's disease - treatment with betahistine hydrochloride","volume":"46","author":"Wolfson","year":"1967","journal-title":"Eye, Ear, Nose, Throat Monthly"},{"issue":"8","key":"10.1002\/14651858.CD015171.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S0022215100094858","article-title":"Flunarizine in the treatment of vertigo","volume":"97","author":"Wouters","year":"1983","journal-title":"Journal of Laryngology and Otology"},{"issue":"4","key":"10.1002\/14651858.CD015171.pub2-BIB0078|cit78","first-page":"987","article-title":"Clinical evaluation of long-term treatment of Meniere's disease with isosorbide multi-centered double-blind trial with betahistine mesylate as a reference drug","volume":"34","author":"Yamazaki","year":"1988","journal-title":"Otologia Fukuoka"},{"issue":"44","key":"10.1002\/14651858.CD015171.pub2-BIB0079|cit79","first-page":"4191","article-title":"Efficacy observation of betahistine in the treatment of dizziness caused by Meniere's disease and the experience of nursing care","volume":"23","author":"Yu","year":"2012","journal-title":"Zhonggou Yaofang [China Pharmacy]"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0080|cit80","unstructured":"A phase II, double-blind, placebo-controlled clinical trial of long term (up to 9 month) daily treatment with two 500mg Valtrex (Valaciclovir) tablets for the chronic suppression of recurrences of Meniere's disease symptoms in participants with a positive herpes serology www.anzctr.org.au"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0081|cit81","unstructured":"Efficacy of antiviral medications in controlling vertigo attacks of patients with Meniere's disease https:\/\/clinicaltrials.gov\/show\/nct01729767"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0082|cit82","doi-asserted-by":"crossref","unstructured":"Committee on Hearing and Equilibrium Guidelines for the Diagnosis and Evaluation of Therapy in Meniere's Disease Otolaryngology \u2013 Head and Neck Surgery 1995 113 3 181 5","DOI":"10.1016\/S0194-5998(95)70102-8"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0083|cit83","first-page":"1462","article-title":"Meniere's disease: Criteria for diagnosis and evaluation of therapy for reporting","volume":"76","author":"Committee on Hearing and Equilibrium","year":"1972","journal-title":"Transactions of the American Academy of Ophthalmology and Otolaryngology"},{"issue":"9","key":"10.1002\/14651858.CD015171.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"e0237532","DOI":"10.1371\/journal.pone.0237523","article-title":"Pharmacologic and surgical therapies for patients with Meniere's disease: a systematic review and network meta-analysis","volume":"15","author":"Ahmadzai","year":"2020","journal-title":"PLOS One"},{"issue":"1","key":"10.1002\/14651858.CD015171.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(85)90115-3","article-title":"Actions of betahistine at histamine receptors in the brain","volume":"111","author":"Arrang","year":"1985","journal-title":"European Journal of Pharmacology"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/archneur.58.7.1151","article-title":"Prosper M\u00e9ni\u00e8re and his disease","volume":"58","author":"Baloh","year":"2001","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11882-012-0258-3","article-title":"Is allergy related to Meniere's disease?","volume":"12","author":"Banks","year":"2012","journal-title":"Current Allergy and Asthma Reports"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0088|cit88","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to Meta-analysis","author":"Borenstein","year":"2009"},{"issue":"4","key":"10.1002\/14651858.CD015171.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/00016489850154658","article-title":"Effects of betahistine on vestibular receptors of the frog","volume":"118","author":"Botta","year":"1998","journal-title":"Archives of Otolaryngology"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000475875","article-title":"Population-based study on the epidemiology of M\u00e9ni\u00e8re's disease","volume":"22","author":"Bruderer","year":"2017","journal-title":"Audiology & Neuro-otology"},{"issue":"4","key":"10.1002\/14651858.CD015171.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"Clinical Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD015171.pub2-BIB0092|cit92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003599.pub2","article-title":"Diuretics for the treatment of M\u00e9ni\u00e8re's disease or syndrome","author":"Burgess","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/anae.13938","article-title":"Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals","volume":"72","author":"Carlisle","year":"2017","journal-title":"Anaesthesia"},{"issue":"1-2","key":"10.1002\/14651858.CD015171.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2005.10.027","article-title":"Histamine (H3) receptors modulate the excitatory amino acid receptor response of the vestibular afferents","volume":"1064","author":"Ch\u00e1vez","year":"2005","journal-title":"Brain Research"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2147\/TACG.S59024","article-title":"The genetics of M\u00e9ni\u00e8re's disease","volume":"8","author":"Chiarella","year":"2015","journal-title":"Application of Clinical Genetics"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/00016489709124019","article-title":"Medical treatment of Meniere's disease: a review of literature","volume":"526","author":"Claes","year":"1997","journal-title":"Acta Oto-laryngologica. Supplementum"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/000164800750044461","article-title":"A review of medical treatment for Meniere's disease","volume":"544","author":"Claes","year":"2000","journal-title":"Acta Oto-laryngologica. Supplementum"},{"issue":"5","key":"10.1002\/14651858.CD015171.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/0194599816630733","article-title":"A systematic review of diuretics in the medical management of Meniere's disease","volume":"154","author":"Crowson","year":"2016","journal-title":"Otolaryngology - Head & Neck Surgery"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.3389\/fimmu.2017.01739","article-title":"Regulation of Fn14 receptor and NF-\u03baB underlies inflammation in Meniere's disease","volume":"8","author":"Frejo","year":"2017","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000189783","article-title":"M\u00e9ni\u00e8re's disease is a viral neuropathy","volume":"71","author":"Gacek","year":"2009","journal-title":"ORL; Journal for Oto-rhino-laryngology and Its Related Specialties"},{"issue":"10","key":"10.1002\/14651858.CD015171.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.autrev.2012.01.004","article-title":"Meniere's disease might be an autoimmune condition?","volume":"11","author":"Greco","year":"2012","journal-title":"Autoimmunity Reviews"},{"issue":"10","key":"10.1002\/14651858.CD015171.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1017\/S0022215100003947","article-title":"Observations on the pathology of M\u00e9ni\u00e8re's syndrome","volume":"53","author":"Hallpike","year":"1938","journal-title":"Journal of Laryngology and Otology"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0103|cit103","unstructured":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0104|cit104","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"g6544","DOI":"10.1136\/bmj.g6544","article-title":"Meniere's disease","volume":"349","author":"Harcourt","year":"2014","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD015171.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000286213","article-title":"Current-day prevalence of M\u00e9ni\u00e8re\u2019s syndrome","volume":"15","author":"Harris","year":"2010","journal-title":"Audiology & Neuro-otology"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0107|cit107","first-page":"595","article-title":"Quantitative evaluation of dizziness characteristics and impact on quality of life","volume":"17","author":"Honrubia","year":"1996","journal-title":"American Journal of Otology"},{"issue":"6","key":"10.1002\/14651858.CD015171.pub2-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3109\/00016480903382808","article-title":"Long-term course of Meni\u00e8re's disease revisited","volume":"130","author":"Huppert","year":"2010","journal-title":"Acta Oto-Laryngologica"},{"issue":"4","key":"10.1002\/14651858.CD015171.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1001\/archotol.1990.01870040046011","article-title":"The development of the Dizziness Handicap Inventory","volume":"116","author":"Jacobsen","year":"1990","journal-title":"Archives of Otolaryngology - Head & Neck Surgery"},{"issue":"6","key":"10.1002\/14651858.CD015171.pub2-BIB0110|cit110","first-page":"804","article-title":"A screening version of the Dizziness Handicap Inventory","volume":"19","author":"Jacobsen","year":"1998","journal-title":"American Journal of Otology"},{"issue":"1","key":"10.1002\/14651858.CD015171.pub2-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001873","article-title":"Betahistine for M\u00e9ni\u00e8re's disease or syndrome","author":"James","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0112|cit112","first-page":"0505","article-title":"Meniere's disease","volume":"Mar 1","author":"James","year":"2007","journal-title":"Clinical Evidence"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/VES-150549","article-title":"Diagnostic criteria for Menie\u0300re\u2019s disease","volume":"25","author":"Lopez-Escamez","year":"2015","journal-title":"Journal of Vestibular Research"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/AUD.0b013e31822f67c0","article-title":"The Tinnitus Functional Index: Development of a new clinical measure for chronic, intrusive tinnitus","volume":"33","author":"Meikle","year":"2012","journal-title":"Ear and Hearing"},{"issue":"4","key":"10.1002\/14651858.CD015171.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/000348949910800403","article-title":"Measuring the effects of Menieres Disease: results of the Patient-Oriented Severity Index (MD POSI) Version 1","volume":"108","author":"Murphy","year":"1999","journal-title":"Annals of Otology, Rhinology and Laryngology"},{"issue":"5","key":"10.1002\/14651858.CD015171.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00405-013-2596-8","article-title":"Meta-analysis of clinical studies with betahistine in Meniere's disease and vestibular vertigo","volume":"271","author":"Nauta","year":"2014","journal-title":"European Archives of Oto-Rhino-Laryngology"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archotol.1996.01890140029007","article-title":"Development of the Tinnitus Handicap Inventory","volume":"122","author":"Newman","year":"1996","journal-title":"Archives of Otolaryngology--Head and Neck Surgery"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0773.1984.tb03625.x","article-title":"Site and mechanism of the action of diuretics","volume":"54","author":"Odlind","year":"1984","journal-title":"Acta Pharmacologica et Toxicologica"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1177\/019459988509300501","article-title":"Committee on hearing and equilibrium guidelines for reporting treatment results in Meniere's disease","volume":"93","author":"Pearson","year":"1985","journal-title":"Otolaryngology - Head and Neck Surgery"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00405-019-05423-7","article-title":"Therapeutic strategies in the treatment of Meni\u00e8re's disease: the Italian experience","volume":"276","author":"Quaranta","year":"2019","journal-title":"European Archives of Oto-Rhino-Laryngology"},{"issue":"12","key":"10.1002\/14651858.CD015171.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3109\/00016489.2015.1072873","article-title":"Use of betahistine in the treatment of peripheral vertigo","volume":"135","author":"Ramos Alcocer","year":"2015","journal-title":"Acta Oto-Laryngologica"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/cge.12150","article-title":"Familial clustering and genetic heterogeneity in Meniere\u2019s disease","volume":"85","author":"Requena","year":"2014","journal-title":"Clinical Genetics"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0123|cit123","unstructured":"Review Manager (RevMan) Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"issue":"8","key":"10.1002\/14651858.CD015171.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"e7068","DOI":"10.5867\/medwave.2017.08.7068","article-title":"Is betahistine effective for Meniere's disease?","volume":"17","author":"Rosenbaum","year":"2017","journal-title":"Medwave"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"e7188","DOI":"10.5867\/medwave.2018.02.7187","article-title":"Are diuretics effective for Meniere's disease?","volume":"18","author":"Rosenbaum","year":"2018","journal-title":"Medwave"},{"issue":"9","key":"10.1002\/14651858.CD015171.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1524-6175.2004.03789.x","article-title":"Diuretic-related side effects: development and treatment","volume":"6","author":"Sica","year":"2007","journal-title":"Journal of Clinical Hypertension"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1258\/0022215053419871","article-title":"A national survey amongst UK otolaryngologists regarding the treatment of M\u00e9ni\u00e8re\u2019s disease","volume":"119","author":"Smith","year":"2005","journal-title":"Journal of Laryngology & Otology"},{"issue":"6","key":"10.1002\/14651858.CD015171.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/00129492-200211000-00022","article-title":"Factors influencing quality of life in patients with M\u00e9ni\u00e8re\u2019s disease, identified by a multidimensional approach","volume":"23","author":"S\u00f6derman","year":"2002","journal-title":"Otology & Neurotology"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7525-7-101","article-title":"Measurement properties of the Dizziness Handicap Inventory by cross-sectional and longitudinal designs","volume":"7","author":"Tamber","year":"2009","journal-title":"Health and Quality of Life Outcomes"},{"issue":"3","key":"10.1002\/14651858.CD015171.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00002060-199905000-00009","article-title":"Short form of the Dizziness Handicap Inventory: construction and validation through Rasch analysis","volume":"78","author":"Tesio","year":"1999","journal-title":"American Journal of Physical Medicine and Rehabilitation"},{"issue":"2","key":"10.1002\/14651858.CD015171.pub2-BIB0131|cit131","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/1751143719900099","article-title":"Community prescribing of potentially nephrotoxic drugs and risk of acute kidney injury requiring renal replacement therapy in critically ill adults: a national cohort study","volume":"22","author":"Tominey","year":"2021","journal-title":"Journal of the Intensive Care Society"},{"issue":"3","key":"10.1002\/14651858.CD015171.pub2-BIB0132|cit132","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1097\/AUD.0000000000000264","article-title":"The cost of M\u00e9ni\u00e8re\u2019s disease: a novel multisource approach","volume":"37","author":"Tyrrell","year":"2016","journal-title":"Ear and Hearing"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000515821","article-title":"Betahistine in Meniere's disease or syndrome: a systematic review","volume":"27","author":"Van Esch","year":"2022","journal-title":"Audiology & Neuro-Otology"},{"issue":"6","key":"10.1002\/14651858.CD015171.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/jamia\/ocx053","article-title":"Identifying reports of randomized controlled trials (RCTs) via a hybrid machine learning and crowdsourcing approach","volume":"24","author":"Wallace","year":"2017","journal-title":"Journal of the American Medical Informatics Association"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Medical Research Methodology"},{"issue":"12","key":"10.1002\/14651858.CD015171.pub2-BIB0136|cit136","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015245","article-title":"Intratympanic corticosteroids for M\u00e9ni\u00e8re\u2019s disease","author":"Webster","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0137|cit137","first-page":"0505","article-title":"Meniere's disease","volume":"Nov 5","author":"Wright","year":"2015","journal-title":"Clinical Evidence"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2021.02.012","article-title":"A proposed framework to guide evidence synthesis practice for meta-analysis with zero-events studies","volume":"135","author":"Xu","year":"2021","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0139|cit139","first-page":"2310","article-title":"Hearing organ of a patient who showed Meniere's symptoms\u00a0[Japanese]","volume":"44","author":"Yamakawa","year":"1938","journal-title":"Journal of the Otolaryngological Society of Japan"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2273.1992.tb01833.x","article-title":"Quantitative analysis of factors contributing to handicap and distress in vertiginous patients: a questionnaire study","volume":"17","author":"Yardley","year":"1992","journal-title":"Clinical Otolaryngology"},{"issue":"8","key":"10.1002\/14651858.CD015171.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0022-3999(92)90131-K","article-title":"Symptoms, anxiety and handicap in dizzy patients: development of the vertigo symptom scale","volume":"36","author":"Yardley","year":"1992","journal-title":"Journal of Psychometric Research"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0142|cit142","first-page":"1136","article-title":"A randomized controlled trial of exercise therapy for dizziness and vertigo in primary care","volume":"48","author":"Yardley","year":"1998","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD015171.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2021.03.026","article-title":"GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings","volume":"137","author":"Zeng","year":"2021","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD015171.pub2-BIB0144|cit144","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015171","article-title":"Systemic pharmacological interventions for M\u00e9ni\u00e8re\u2019s disease","author":"Webster","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T09:02:42Z","timestamp":1768899762000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD015171.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane ENT Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":144,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd015171.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]}}}